
|Slideshows|April 17, 2019
Highs and Lows in New Bipolar Research
Author(s)Leo Robert
Recent study results offer some good news and some bad. A concise summary of key findings here.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves Tauklarify (MK-6240) For Tau Pathology Detection in Alzheimer Disease
2
Experience With Xanomeline/Trospium in an Acute Inpatient Setting Treating Individuals With Schizophrenia
3
Phase 4 Trial of Viloxazine ER Shows Real-World Gains for ADHD With Comorbid Depression, Anxiety
4
DT120 (Lysergide) Shows Rapid, Lasting Relief for Generalized Anxiety in Phase 3 Trial
5









